PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges as they…
Plan sponsors face an increasingly complex challenge: effectively managing the high costs of innovative and life-changing medications while providing appropriate treatments for their employees and…
Gain insights into biosimilar strategies from our 2024 Trends in Specialty Drug Benefits Report On April 29th, we released our highly anticipated 2024 Trends…
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges as they…
